Relying on the secretion of interferon-gamma (IFNγ), we repeatedly observed increased major histocompatibility complex (MHC)-dependent tumor reactivity of CB CD8+ T cells versus paired samples from tumor or peripheral blood (Fig. 2k,l). The gene discussed is CD8A; the disease is neoplasm.